If you’re a life sciences company based in British Columbia and want to move from research to commercial sales, funding is often the main challenge. The Genome BC Industry Innovation Fund—officially called the Industry Innovation Program (I2)—helps bridge that gap by supporting late-stage commercialization. The program offers large, multi-year funding, but you must meet strict eligibility rules and secure matching funds. This program is only available to companies with operations in British Columbia.
The Industry Innovation Program (I2) is a Genome BC funding program for small and medium-sized enterprises (SMEs) that are commercializing life sciences technologies in British Columbia. The focus is on moving proven technologies to market-ready products and generating revenue within a set timeline. The program does not support early research.
Key program facts:
Life sciences is defined broadly and includes genomics-enabled solutions in areas such as:
To apply, your business must meet all core eligibility criteria. Genome BC reviews applications closely, and missing even one requirement can lead to rejection.
Your company must:
Genome BC expects clear evidence that your technology works and that customers are willing to pay for it. The program does not support discovery or feasibility work.
Funding from the Genome BC Industry Innovation Fund is significant compared to many other provincial programs.
Typical funding range:
The exact amount depends on factors like:
Funding is usually paid in milestones. Each payment is tied to progress reports and deliverables.
Matching funds are a key requirement for this program.
Matching requirement:
Acceptable matching sources include:
Genome BC checks where your matching funds come from and whether they are committed. Letters of support and signed agreements are important.
Tools like GrantHub’s eligibility matcher can help you find other provincial or federal programs that may be used as matching funding, filtered by industry and location. This can make it easier to meet the matching requirement.
The application process is structured and competitive. You should plan ahead and gather all needed documents before you start.
Typical steps include:
Project concept development
Define your commercialization milestones, budget, and timeline.
Secure matching funds early
Genome BC expects proof that matching funds are realistic and achievable.
Prepare the full application
Include technical details, market analysis, IP position, and financial forecasts.
Genome BC review and due diligence
Expert reviewers and Genome BC staff assess each application.
Funding decision and agreement
Approved projects sign a funding agreement with reporting requirements.
Application intake dates may be continuous or round-based, depending on available funding.
1. Treating I2 like an R&D grant
This program funds commercialization, not early research. Weak revenue plans are a common reason for rejection.
2. Unclear matching funds
Verbal commitments are not enough. Genome BC wants documented, credible sources.
3. Weak IP position
If you don’t clearly own or control the IP, your application is unlikely to move forward.
4. Overpromising timelines
Commercialization must be realistic within four years. Reviewers will question unrealistic projections.
Q: Is the Genome BC Industry Innovation Fund only for genomics companies?
Not strictly. Your technology must be life sciences–based and genomics-enabled, but this includes digital health and precision medicine applications.
Q: Do startups qualify, or only established companies?
Startups can apply if they meet the SME definition and show a credible path to revenue within four years.
Q: Is matching funding required before applying?
You don’t always need all funds in hand at submission, but Genome BC expects strong evidence that matching funds are secured or highly likely.
Q: Can Genome BC funding affect SR&ED claims?
Yes. Genome BC funding is considered government assistance and may reduce eligible SR&ED expenditures.
Q: How competitive is the Industry Innovation Program?
It is very competitive. Projects are assessed on commercial impact, not just scientific merit.
The Genome BC Industry Innovation Fund can help your business reach the market, but only if you are truly ready for commercialization and have matching funds in place. GrantHub tracks hundreds of active life sciences and commercialization grants across Canada, including programs that may complement Genome BC funding. Reviewing these options before you apply is a smart next step.
Was this article helpful?
Rate it so we can improve our content.
Canada Proactive Disclosure Data
The Canadian government has funded over 400,000 businesses through 1.27 million grants and contributions. Check your eligibility in 60 seconds.